US Patent 8334373 Nuclease resistant double-stranded ribonucleic acid
Patent 8334373 was granted and assigned to Alnylam Pharmaceuticals on December, 2012 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8334373 Nuclease resistant double-stranded ribonucleic acid
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
